Mental Health and Substance Use Associated with Hospitalization among People with COVID-19: A Population-Based Cohort Study.
Adult
Age Factors
Aged
Aged, 80 and over
British Columbia
/ epidemiology
COVID-19
/ complications
Cohort Studies
Comorbidity
Female
Hospitalization
Humans
Male
Mental Disorders
/ complications
Mental Health
Middle Aged
Pregnancy
Pregnancy Complications, Infectious
Risk Factors
Sex Factors
Substance-Related Disorders
/ complications
Young Adult
COVID-19
cohort studies
diabetes mellitus
hospitalization
intellectual disability
mental health
pregnancy
registries
risk factors
substance-related disorders
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
31 10 2021
31 10 2021
Historique:
received:
29
09
2021
revised:
23
10
2021
accepted:
28
10
2021
entrez:
27
11
2021
pubmed:
28
11
2021
medline:
15
12
2021
Statut:
epublish
Résumé
This study identified factors associated with hospital admission among people with laboratory-diagnosed COVID-19 cases in British Columbia. The study used data from the BC COVID-19 Cohort, which integrates data on all COVID-19 cases with data on hospitalizations, medical visits, emergency room visits, prescription drugs, chronic conditions and deaths. The analysis included all laboratory-diagnosed COVID-19 cases in British Columbia to 15 January 2021. We evaluated factors associated with hospital admission using multivariable Poisson regression analysis with robust error variance. Of the 56,874 COVID-19 cases included in the analysis, 2298 were hospitalized. Factors associated with increased hospitalization risk were as follows: male sex (adjusted risk ratio (aRR) = 1.27; 95% CI = 1.17-1.37), older age (
Identifiants
pubmed: 34835002
pii: v13112196
doi: 10.3390/v13112196
pmc: PMC8624346
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : CIHR
ID : VR5-172683
Pays : Canada
Organisme : CIHR
ID : OV4-170361
Pays : Canada
Références
Clin Infect Dis. 2021 Jun 1;72(11):e695-e703
pubmed: 32945846
Psychiatr Serv. 2021 May 1;72(5):578-581
pubmed: 33138712
Mol Psychiatry. 2021 Jan;26(1):30-39
pubmed: 32929211
J Med Virol. 2021 Feb;93(2):907-915
pubmed: 32706392
BMJ. 2020 Sep 1;370:m3320
pubmed: 32873575
Lancet Respir Med. 2020 May;8(5):506-517
pubmed: 32272080
EBioMedicine. 2016 Oct;12:189-195
pubmed: 27596150
CMAJ. 2021 May 17;193(20):E723-E734
pubmed: 33906966
PLoS One. 2021 Mar 4;16(3):e0247461
pubmed: 33661992
J Gerontol A Biol Sci Med Sci. 2020 Oct 15;75(11):2224-2230
pubmed: 32687551
Mayo Clin Proc. 2020 Oct;95(10):2189-2203
pubmed: 33012349
Am J Obstet Gynecol MFM. 2021 May;3(3):100319
pubmed: 33493707
Lancet. 2021 Jun 26;397(10293):2461-2462
pubmed: 34139198
MMWR Morb Mortal Wkly Rep. 2020 Nov 06;69(44):1641-1647
pubmed: 33151921
Clin Infect Dis. 2021 Mar 1;72(5):e162-e166
pubmed: 33270136
Lancet Psychiatry. 2021 Sep;8(9):797-812
pubmed: 34274033
Front Med (Lausanne). 2020 Jun 23;7:348
pubmed: 32671082
Am J Obstet Gynecol. 2020 Nov;223(5):764-768
pubmed: 32730899
Anaesthesia. 2020 Jul;75(7):928-934
pubmed: 32246838
BMJ. 2020 May 22;369:m1966
pubmed: 32444366
PLoS One. 2020 Nov 3;15(11):e0241536
pubmed: 33141862
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
J Clin Invest. 2020 Nov 2;130(11):6141-6150
pubmed: 32764200
Int J Drug Policy. 2018 May;55:31-39
pubmed: 29482150
Nature. 2020 Dec;588(7837):315-320
pubmed: 32846427
J Ovarian Res. 2020 Nov 24;13(1):137
pubmed: 33234144
Lancet Diabetes Endocrinol. 2020 Oct;8(10):823-833
pubmed: 32798471